Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Atavistik Bio, Inc
University of Kansas Medical Center
Seagen Inc.
M.D. Anderson Cancer Center
Sun Yat-sen University
University Health Network, Toronto
University Health Network, Toronto
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Arcus Biosciences, Inc.
Qurient Co., Ltd.
Institut du Cancer de Montpellier - Val d'Aurelle
Institute of Cancer Research, United Kingdom
AbbVie
AstraZeneca
National Institutes of Health Clinical Center (CC)
University of Oklahoma
Jonsson Comprehensive Cancer Center
University of Kansas Medical Center
City of Hope Medical Center
Beth Israel Deaconess Medical Center
H. Lee Moffitt Cancer Center and Research Institute
University of Rochester
ImmunityBio, Inc.
Beth Israel Deaconess Medical Center
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Huazhong University of Science and Technology
Brigham and Women's Hospital
National Institutes of Health Clinical Center (CC)
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Université de Sherbrooke
University of Kentucky
HiFiBiO Therapeutics
Akeso
TScan Therapeutics, Inc.
TScan Therapeutics, Inc.
Weill Medical College of Cornell University
National Cancer Institute (NCI)
Mayo Clinic
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Baylor College of Medicine
Merck Sharp & Dohme LLC
Jhpiego
Abramson Cancer Center at Penn Medicine